share_log

Redhill Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-CVI Investments, Inc.(5.9%),Heights Capital Management, Inc.(5.9%)

SEC announcement ·  Feb 1 10:26
Summary by Moomoo AI
On January 25, 2024, CVI Investments, Inc., with Heights Capital Management, Inc. as its investment manager, filed a Schedule 13G with the Securities and Exchange Commission, disclosing a 5.9% ownership stake in RedHill Biopharma Ltd., amounting to 700,000,000 shares. This stake is represented by 1,750,000 American Depositary Shares, following the company's recent share offering completion. The filing, made under Rule 13d-1(c), indicates that the shares were not acquired for the purpose of changing or influencing the control of RedHill Biopharma. Both CVI Investments and Heights Capital Management are organized under the laws of the Cayman Islands and Delaware, respectively. The filing was certified by Brian Sopinsky, Secretary of both entities, on February 1, 2024.
On January 25, 2024, CVI Investments, Inc., with Heights Capital Management, Inc. as its investment manager, filed a Schedule 13G with the Securities and Exchange Commission, disclosing a 5.9% ownership stake in RedHill Biopharma Ltd., amounting to 700,000,000 shares. This stake is represented by 1,750,000 American Depositary Shares, following the company's recent share offering completion. The filing, made under Rule 13d-1(c), indicates that the shares were not acquired for the purpose of changing or influencing the control of RedHill Biopharma. Both CVI Investments and Heights Capital Management are organized under the laws of the Cayman Islands and Delaware, respectively. The filing was certified by Brian Sopinsky, Secretary of both entities, on February 1, 2024.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more